Mark Stow

580 total citations
8 papers, 165 citations indexed

About

Mark Stow is a scholar working on Molecular Biology, Oncology and Hematology. According to data from OpenAlex, Mark Stow has authored 8 papers receiving a total of 165 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 3 papers in Oncology and 2 papers in Hematology. Recurrent topics in Mark Stow's work include Bone health and treatments (2 papers), Bone Metabolism and Diseases (2 papers) and Amino Acid Enzymes and Metabolism (1 paper). Mark Stow is often cited by papers focused on Bone health and treatments (2 papers), Bone Metabolism and Diseases (2 papers) and Amino Acid Enzymes and Metabolism (1 paper). Mark Stow collaborates with scholars based in United Kingdom, United States and Germany. Mark Stow's co-authors include Adrienne M. Flanagan, George I. Moonsammy, Jessica A. Chichester, Vidadi Yusibov, R. Mark Jones, Stephen J. Streatfield, Brian J. Green, Richard Williams, Ashfaq A. Parkar and R A Jupp and has published in prestigious journals such as Journal of Pharmacology and Experimental Therapeutics, The Journal of Pathology and Journal of Immunological Methods.

In The Last Decade

Mark Stow

8 papers receiving 152 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mark Stow United Kingdom	8	88	46	37	37	28	8	165
Graham Belfield United Kingdom	9	257 2.9×	48 1.0×	14 0.4×	39 1.1×	28 1.0×	19	362
Wesley Huang United States	6	187 2.1×	29 0.6×	29 0.8×	59 1.6×	25 0.9×	14	274
Geniver El Tekle United States	3	165 1.9×	43 0.9×	33 0.9×	62 1.7×	20 0.7×	3	267
Zhongyi Liu China	9	114 1.3×	27 0.6×	23 0.6×	54 1.5×	80 2.9×	13	243
Vanessa Andries Belgium	9	190 2.2×	11 0.2×	42 1.1×	47 1.3×	30 1.1×	16	303
Xiu Teng China	9	74 0.8×	12 0.3×	24 0.6×	32 0.9×	97 3.5×	15	199
Malissa Diehl United States	7	84 1.0×	24 0.5×	10 0.3×	41 1.1×	65 2.3×	8	199
Zhao Gan China	4	202 2.3×	47 1.0×	24 0.6×	102 2.8×	64 2.3×	17	321
Sandra A. Vloemans Netherlands	7	166 1.9×	30 0.7×	7 0.2×	28 0.8×	110 3.9×	14	309
Hisako Hashimoto Japan	10	261 3.0×	21 0.5×	20 0.5×	46 1.2×	13 0.5×	15	352

Countries citing papers authored by Mark Stow

Since Specialization

Citations

This map shows the geographic impact of Mark Stow's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Stow with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Stow more than expected).

Fields of papers citing papers by Mark Stow

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Stow. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Stow. The network helps show where Mark Stow may publish in the future.

Co-authorship network of co-authors of Mark Stow

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Stow. A scholar is included among the top collaborators of Mark Stow based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Stow. Mark Stow is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

Chichester, Jessica A., R. Mark Jones, Brian J. Green, et al.. (2012). Safety and Immunogenicity of a Plant-Produced Recombinant Hemagglutinin-Based Influenza Vaccine (HAI-05) Derived from A/Indonesia/05/2005 (H5N1) Influenza Virus: A Phase 1 Randomized, Double-Blind, Placebo-Controlled, Dose-Escalation Study in Healthy Adults. Viruses. 4(11). 3227–3244. 55 indexed citations

Liu, Phillip C.C., Reid Huber, Mark Stow, et al.. (2003). Induction of endogenous genes by peroxisome proliferator activated receptor alpha ligands in a human kidney cell line and in vivo. The Journal of Steroid Biochemistry and Molecular Biology. 85(1). 71–79. 12 indexed citations

Ho, Siew Peng, et al.. (2002). Antisense Oligonucleotides Selectively Regulate Aspartyl β-Hydroxylase and Its Truncated Protein Isoform in Vitro but Distribute Poorly into A549 Tumors in Vivo. Journal of Pharmacology and Experimental Therapeutics. 302(2). 795–803. 20 indexed citations

Lindauer, Klaus, Ashfaq A. Parkar, Ian Hayes, et al.. (2001). Analysis of cellular adhesion by microarray expression profiling. Journal of Immunological Methods. 250(1-2). 15–28. 9 indexed citations

Parkar, Ashfaq A., et al.. (2000). Large-Scale Expression, Refolding, and Purification of the Catalytic Domain of Human Macrophage Metalloelastase (MMP-12) in Escherichia coli. Protein Expression and Purification. 20(2). 152–161. 28 indexed citations

Flanagan, Adrienne M., Mark Stow, & Richard Williams. (1995). The effect of interleukin‐6 and soluble interleukin‐6 receptor protein on the bone resorptive activity of human osteoclasts generated in vitro. The Journal of Pathology. 176(3). 289–297. 15 indexed citations

Flanagan, Adrienne M., et al.. (1995). The role of 1,25-dihydroxycholecalciferol and prostaglandin E2 in the regulation of human osteoclastic bone resorption in vitro.. PubMed. 76(1). 37–42. 13 indexed citations

Scott, B B, et al.. (1993). Molecular mechanisms resulting in pathogenic anti-mouse erythrocyte antibodies in New Zealand black mice. Clinical & Experimental Immunology. 93(1). 26–33. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact